As a new potential tumor-related biomarker, whether RBM10 can provide us with new means and strategies for the early diagnosis, targeted drug therapy, and curative effect prediction of lung adenocarcinoma remains to be studied [38,39,40]. This evidence concerns the gene RBM10 and neoplasm.